Compounds > 1,2-dipalmitoylphosphatidylcholine
Page last updated: 2024-08-17

1,2-dipalmitoylphosphatidylcholine and Lung Injury, Acute

1,2-dipalmitoylphosphatidylcholine has been researched along with Lung Injury, Acute in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Banerjee, R; Kaviratna, AS1
Notter, RH; Willson, DF1

Reviews

1 review(s) available for 1,2-dipalmitoylphosphatidylcholine and Lung Injury, Acute

ArticleYear
The future of exogenous surfactant therapy.
    Respiratory care, 2011, Volume: 56, Issue:9

    Topics: 1,2-Dipalmitoylphosphatidylcholine; Acute Lung Injury; Animals; Extracorporeal Membrane Oxygenation; Humans; Infant, Newborn; Pulmonary Surfactants; Respiratory Distress Syndrome; Respiratory Distress Syndrome, Newborn

2011

Other Studies

1 other study(ies) available for 1,2-dipalmitoylphosphatidylcholine and Lung Injury, Acute

ArticleYear
Nanovesicle aerosols as surfactant therapy in lung injury.
    Nanomedicine : nanotechnology, biology, and medicine, 2012, Volume: 8, Issue:5

    Topics: 1,2-Dipalmitoylphosphatidylcholine; Acute Lung Injury; Aerosols; Animals; Bronchoalveolar Lavage Fluid; Cell Line, Tumor; Drug Carriers; Humans; Mice; Nanoparticles; Phosphatidylethanolamines; Surface-Active Agents

2012